Cytosorbents Corp 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Cytosorbents Corporation on December 18, 2014. The report details a significant corporate event regarding the listing status of the Company's common stock.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event rather than financial performance.
Material Changes
- Stock Listing Transfer: The Company announced the transfer of its common stock from the OTCQB Marketplace to the NASDAQ Capital Market.
- Trading Symbol: The stock will trade under the symbol "CTSO."
- Effective Date: Trading on the NASDAQ Capital Market is expected to begin on or about December 23, 2014.
- Historical Context: The stock had been trading on the OTCQB Marketplace since August 9, 2006.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future performance, or specific risk factors beyond the standard disclosure of the listing change. The primary event is the successful upgrade of the trading venue.
Key Facts for Investor Verification
- Confirm the commencement of trading on the NASDAQ Capital Market under the symbol "CTSO" on or after December 23, 2014.
- Verify the press release attached as Exhibit 99.1 for additional details on the listing process.
- Note that this filing does not include updated financial statements or operational metrics.